Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children

NCT ID: NCT07086612

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-01

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

OSAHS (Obstructive Sleep Apnea Hypopnea Syndrome) in children is a frequent respiratory disorder, whose prevalence is estimated at between 1.2 and 5.7%, and which, if left untreated, can cause severe medical complications. This prevalence tends to be underestimated. Diagnosis is made following a clinical examination noting the presence of characteristic clinical and polysomnographic criteria. Multidisciplinary management has been widely described in the literature, and various therapeutic options have been indicated. Rapid maxillary expansion has proved highly effective in the treatment of this condition. This syndrome is a real public health problem and must be diagnosed as early as possible. Through our research, we would like to study whether there is a causal link between an orthodontic problem of the transverse direction and the presence of SAHOS in children. In other words, we would like to assess whether children who clinically present an orthodontic deficiency of their transverse dimension are more likely to develop SAHOS than children without this deficit. If this proves to be true, then a new clinical sign could enable certain healthcare professionals to detect this syndrome early, and be able to refer patients to physicians as soon as possible.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea Transverse Maxillary Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

transverse deficiency maxilla

patient with transverse deficiency maxilla

Group Type EXPERIMENTAL

over nigtht ventilatory polysomnograph test

Intervention Type DIAGNOSTIC_TEST

Every patient will have an overnight polysomnography test.

other type of maxilla deficiency

patient with other type maxilla deficiency

Group Type OTHER

over nigtht ventilatory polysomnograph test

Intervention Type DIAGNOSTIC_TEST

Every patient will have an overnight polysomnography test.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

over nigtht ventilatory polysomnograph test

Every patient will have an overnight polysomnography test.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged between 6 and 16 years
* Patients with a transverse orthodontic deficiency (group "CAS")
* Patients with another type of orthodontic deficiency (group "CONTROL") such as tooth rotation, crowding, mild Angle Class II or Class III dental occlusion
* Patient who has given free, informed oral consent
* Patient whose legal representatives have given their free written consent
* Patient affiliated with a health insurance scheme

Exclusion Criteria

* Patients refusing to participate in the study
* Patients whose legal representatives refuse to participate in the study
Minimum Eligible Age

6 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation HĂ´pital Saint-Joseph

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'orthopédie dento-cranio-maxillo faciale

Rouen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Perrine KRUK, MD

Role: primary

+3344127963

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00478-41

Identifier Type: OTHER

Identifier Source: secondary_id

761-ASCOT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Video-respiratory Polygraphy in Children
NCT06287333 NOT_YET_RECRUITING
Myofunctional Therapy for Children With OSA
NCT07249944 NOT_YET_RECRUITING NA